Correlation Between Pfizer and Exagen
Can any of the company-specific risk be diversified away by investing in both Pfizer and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Exagen Inc, you can compare the effects of market volatilities on Pfizer and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Exagen.
Diversification Opportunities for Pfizer and Exagen
Very good diversification
The 3 months correlation between Pfizer and Exagen is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Pfizer i.e., Pfizer and Exagen go up and down completely randomly.
Pair Corralation between Pfizer and Exagen
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Exagen. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 6.9 times less risky than Exagen. The stock trades about -0.05 of its potential returns per unit of risk. The Exagen Inc is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 428.00 in Exagen Inc on December 28, 2024 and sell it today you would lose (4.00) from holding Exagen Inc or give up 0.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Exagen Inc
Performance |
Timeline |
Pfizer Inc |
Exagen Inc |
Pfizer and Exagen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Exagen
The main advantage of trading using opposite Pfizer and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |